Table 3. Regions showing more suppression on 200 mg CRF-R1 antagonist during Extinction in IBS compared to HCs.
ROI | HEMI | cluster P | cluster k | VOXEL p | Zequiv | X | Y | Z |
---|---|---|---|---|---|---|---|---|
mPFC | L | 0.037 | 50 | 0.042 | 3.81 | −12 | 48 | −2 |
mPFC | R | 0.042 | 39 | 0.086 | 3.52 | 16 | 48 | −2 |
Pons | L | 0.017 | 26 | 0.023 | 3.51 | −10 | −36 | −40 |
Pons | R | 0.039 | 8 | 0.026 | 3.46 | 2 | −24 | −40 |
aINS | L | 0.037 | 16 | 0.032 | 3.52 | −36 | 34 | 0 |
Hippocampus | R | 0.007 | 23 | 0.004 | 3.67 | 32 | −30 | −10 |